Search | Page 10 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Myeloablative Unrelated Donor Cord Blood Transplantation With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cells for Patients With High Risk Hematological Malignancies

    ... Admit to hospital. Line insertion 6 days before transplant Fludarabine (chemotherapy) Cyclophosphamide (chemotherapy) 5 days before transplant Fludarabine Thiotepa 4 days before transplant Fludarabine Thiotepa 3 days ...

    Clinical Trial last updated 04/29/2016 - 1:33pm.

  2. Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

    ... Cyclosporine Fludarabine Mycophenolate Mofetil ... A Neoral OL 27-400 Sandimmun Sandimmune SangCya Drug: Fludarabine Phosphate Given IV Other Names: 2-F-ara-AMP 9H-Purin-6-amine, ...

    Clinical Trial last updated 04/28/2016 - 1:52pm.

  3. Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide

    ... Cyclophosphamide Fludarabine Mycophenolate Mofetil ... Bone Marrow Transplant Preparative regimen consists of Fludarabine - 30 mg/m2/day , Cytoxan - 14.5 mg/kg/day , and Total Body ...

    Clinical Trial last updated 05/02/2016 - 2:38pm.

  4. Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes

    ... Cyclosporine Fludarabine Mycophenolate Mofetil ... Cord Blood Progenitor Cell Infusion Given IV Drug: Fludarabine Phosphate Given IV Other Names: 2-F-ara-AMP 9H-Purin-6-amine, ...

    Clinical Trial last updated 04/27/2016 - 1:17pm.

  5. Intra-Osseous Co-Transplant of UCB and hMSC

    ... Cyclosporine Fludarabine Mycophenolate Mofetil ... Cytoxan Endoxan Endoxana Drug: fludarabine phosphate Given by IV during prep at 40mg/m2 for 5 days ...

    Clinical Trial last updated 05/02/2016 - 11:15am.

  6. Total Marrow Irradiation for Refractory Acute Leukemia

    ... Cyclosporine Fludarabine Phase:  Phase 1 ... day + 180 post-transplant. Other Name: CSA Drug: Fludarabine 25 mg/m2/day intravenous as a 1 hour infusion for consecutive ...

    Clinical Trial last updated 05/02/2016 - 9:22am.

  7. Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.

    ... Cyclophosphamide Fludarabine Mycophenolate Mofetil ... Intervention:  Other: fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor ...

    Clinical Trial last updated 04/29/2016 - 3:51pm.

  8. Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor

    ... Antithymocyte Globulin Fludarabine Gender:  Female ... total-body irradiation (TBI) Drug: thiotepa Drug: fludarabine phosphate Drug: melphalan Biological: anti-thymocyte ...

    Clinical Trial last updated 04/29/2016 - 1:59pm.

  9. Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia

    ... Cyclophosphamide Fludarabine Mycophenolate Mofetil ... 0.5 mg/kg IV on Day -9 2 mg/kg IV on Days -8, -7 Drug: Fludarabine 30 mg/M2 IV on days -6 to -2 Drug: Cyclophosphamide ...

    Clinical Trial last updated 04/21/2016 - 1:19pm.

  10. Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

    ... Associated Drug(s):  Fludarabine Phase:  Phase 1 ... disease Drug: Conditioning Chemotherapy Fludarabine:30 mg/m2 per day IV infusion over 30 minutes, daily On days -6, -5, ...

    Clinical Trial last updated 04/29/2016 - 1:00pm.